Key result
This review highlights the proposed biological drivers that likely play a deterministic role in the cardiovascular outcomes of patients with type 2 diabetes mellitus.
This review summarizes the biological drivers linking type 2 diabetes mellitus to increased risk of atherosclerotic vascular disease and adverse cardiovascular events.
Type 2 diabetes mellitus is increasing in prevalence, and is a potent risk factor for the development of atherosclerotic vascular disease and increased risk of adverse cardiovascular events. Approximately 15—25% of patients presenting with ischaemic heart disease have a history of diabetes mellitus. This cohort of patients continues to be at heightened short and long-term risk. This review highlights the many proposed biological drivers that likely play a deterministic role in the cardiovascular outcome of patients with type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Steven P. Marso (2002) conducted a review in Type 2 diabetes mellitus and cardiovascular disease. This review highlights the proposed biological drivers that likely play a deterministic role in the cardiovascular outcomes of patients with type 2 diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: